SLC4A7

Chr 3

solute carrier family 4 member 7

Also known as: NBC2, NBC3, NBCN1, SBC2, SLC4A6

The sodium bicarbonate cotransporter encoded by this gene transports sodium and bicarbonate ions in a 1:1 ratio to regulate intracellular pH, particularly important for visual and auditory sensory transmission, macrophage function, and cellular nucleotide synthesis. Mutations cause autosomal recessive retinal dystrophy with early-onset hearing loss and intellectual disability. This gene is highly constrained against loss-of-function variants (LOEUF 0.34), indicating that such mutations are likely to have significant clinical consequences.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.34
Clinical SummarySLC4A7
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.74) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
17 unique Pathogenic / Likely Pathogenic· 110 VUS of 173 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.34LOEUF
pLI 0.736
Z-score 5.54
OE 0.21 (0.130.34)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
2.25Z-score
OE missense 0.75 (0.700.81)
485 obs / 645.6 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.21 (0.130.34)
00.351.4
Missense OE0.75 (0.700.81)
00.61.4
Synonymous OE1.06
01.21.6
LoF obs/exp: 12 / 57.2Missense obs/exp: 485 / 645.6Syn Z: -0.66
DN
0.5772th %ile
GOF
0.6443th %ile
LOF
0.50top 25%

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and loss-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
LOFLOEUF 0.34

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

173 submitted variants in ClinVar

Classification Summary

Pathogenic16
Likely Pathogenic1
VUS110
Likely Benign14
16
Pathogenic
1
Likely Pathogenic
110
VUS
14
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
16
0
16
Likely Pathogenic
0
0
1
0
1
VUS
0
105
5
0
110
Likely Benign
0
4
3
7
14
Benign
0
0
0
0
0
Total0109257141

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SLC4A7 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC